Aquis weekly movers: Rogue Baron off the drink and exploring for assets

Rogue Baron (LON: SHNJ) has decided to change its strategy from drinks, because of a lack of market support for the sector, to natural resources, particularly in North America. The spirits business will be sold. The disposal will turn Rogue Baron into an Enterprise Company on Aquis. An investment committee of Hamish Harris and Charlie Wood will consider potential investments base or precious metals. The company name will change to Richmond Hill Resources. Tomoya Daimon has resigned from the board. A placing raised £209,000 0.6p/share. The share price jumped 164% at 0.725p.

Marula Mining (LON: MARU) says assay results of copper concentrate samples from the Kinusi copper mine in Tanzania provide further confirmation of high-grade copper content of the material stockpile. The share price increased 36.1% to 6.125p.

- Advertisement -

Ananda Pharma (LON: ANA) chief executive Melissa Sturgess bought 5 million shares at 0.43p each, taking her shareholding above 10%. The share price rose 18% to 0.525p.

Third quarter revenue from emissions reduction additives supplier SulNOx Group (LON: SNOX) more than doubled to £208,000 compared to the same period last year. Volume growth was 88.7%. There was cash of £2.5m at the end of 2024. There are 44 shipping companies evaluating the additives and there are more set to sign up. Crystal is the first cruise operator to evaluate the additive, and it made an average fuel saving of 3.4%. The share price improved 8.7% to 87.5p.

Oscillate (LON: MUSH) says it has analysed early-stage data for hydrogen in the Animikie Basin in northern Minnesota. Soil gas sensing equipment has been deployed, and shallow soil gas sampling technology will evaluate hydrogen potential. The share price is 1.92% higher at 0.53p.

Shepherd Neame (LON: SHEP) has amended an earlier purchase by chairman Richard Oldfield (that was said to be 42,459 shares) to 1,500 shares at 519p each. He has also acquired a further 2,000 shares at 540p each. The share price edged up 1.83% to 555p.

- Advertisement -

FALLERS

Cellular medicines developer Cardiogeni (LON: CGNI) joined Aquis on Friday 31 January and the share price slumped to 60p. The subscription price ahead of the flotation was 147p, when £1.44m was raised. This week the share price fell by one-quarter to 45p. On Monday there were two buys of 150 shares each at 66p/share. This was followed later in the week by a sale of 20,000 shares at 25p each and a sale of 220 shares at 41p each. The company’s CLXR-001 product is targeting the cardiac market, specifically coronary artery bypass grafting.

DXS International (LON: DXSP) chairman Bob Sutcliffe is continuing to buy shares adding another 20,000 at 3.5p each, taking his stake to 1.99%. The share price declined 15.4% to 2.75p.

Coinsilium Group Ltd (LON: COIN) is rebranding its Nifty Labs subsidiary as Forza (Gibraltar) and it will focus on treasury management for the holding company. Coinsilium is assessing innovative opportunities in treasury management. The share price slipped 9.33% to 3.4p.

Oberon Investments Group (LON: OBE) is holding a general meeting to gain approval for a capital reduction to create distributable reserves. The share price dipped 2.17% to 4.5p.

Supernova Digital Assets (LON: SOL) generated revenues of £114,000 in the 12 months to October 2024 according to unaudited management accounts. A £2.7m increase in the fair value of digital assets and tokens. The pre-tax profit was £2.41m. Net assets were £5.8m at the end of October 2024. The share price decreased 1.54% to 0.32p.

Latest News

Subscribe to the UK Investor Magazine email newsletter

Register for our free email newsletter and receive the latest investment news, podcasts, event information and offers.

More Articles Like This